CNE1000020H3
CNE1000020H3
MAKER BIOTECHNOLOGY
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 5.79B EUR | 4.99B EUR | 6.48B EUR |
Enterprise Value | 5.94B EUR | 5.17B EUR | 6.74B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | 11.01x | -- | -- |
Price to Sales | 2.72x | 2.31x | 3.07x |
Price to Book | 0.92x | 0.79x | 1.03x |
EV/Revenue | 2.79x | 2.39x | 3.19x |
EV/EBITDA | 16.9x | -- | -- |
Price to FCF (P/FCF) | 31.2x | 206.85x | -- |
EV/FCF | 32.02x | 213.96x | -- |
FCF Yield | 3.2% | 0.48% | -1.48% |